07:00 , Jun 28, 2012 |  BC Innovations  |  Targets & Mechanisms

Endostatin for fibrosis

University of Pittsburgh School of Medicine researchers have shown that a compound derived from endostatin prevented and reversed organ fibrosis in mice.1 The findings may suggest a new use for endostatin, which is approved in...
08:00 , Feb 9, 2004 |  BC Week In Review  |  Company News

Alchemgen Therapeutics Inc., EntreMed, The Children's Medical Center Corp. deal

ENMD transferred to Alchemgen and the Children's Medical Center all rights to its endostatin and angiostatin therapeutic protein programs. Alchemgen will have rights in Asia, while Children's will have rights elsewhere. ENMD will receive upfront...
08:00 , Feb 4, 2004 |  BC Extra  |  Company News

EntreMed transfers its angiostatin, endostatin rights

ENMD transferred to Alchemgen (Houston, Texas) and to Children's Medical Center Corp. (Boston, Mass.) all rights to its endostatin and angiostatin therapeutic protein programs. Alchemgen will have rights in Asia, while Children's will have rights...